NCT00237861View on ClinicalTrials.gov

Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

December 31, 2002

Conditions
Schizophrenia
Interventions
DRUG

risperidone

DRUG

olanzapine

DRUG

quetiapine

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Yale University

OTHER

NCT00237861 - Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia | Biotech Hunter | Biotech Hunter